lifemd inc said it priced its previously announced underwritten registered public offering of 33 million common shares at 6 a share the company said it expects to see proceeds of 20 million lifemd has granted the underwriters a 30day option to purchase 500000 additional shares of common stock at the public offering price less underwriting discounts and commissions the offering is expected to close on oct 4 the company said it intends to use the proceeds from the offering to repay a portion of its indebtedness and the remaining net proceeds for working capital and general corporate purposes including but not limited to new patient customer acquisition expenses and capital expenditures lifemd shares were down 11 to 610 in premarket trading